What are the opening hours?

Monday 08:30 - 17:30 Tuesday 08:30 - 17:30 Wednesday 08:30 - 17:30 Thursday 08:30 - 17:30 Friday 08:30 - 17:30 Saturday 08:30 - 12:30

Curie Oncology

Home
Singapore
Singapore
Curie Oncology

Our caring doctors and nurses at Curie Oncology offer our patients prompt and accurate detection, diagnosis, treatment, support and follow up care.

We provide advance cancer care in a holistic and supportive environment for the patient and their family.

05/01/2026

We are proud to share that Dr. Choo Su Pin was invited as a speaker at a China online symposium dedicated to precision treatment for gastric cancer.

The symposium brought together leading oncology experts from China to discuss the latest clinical advances, treatment strategies, and real-world experiences in gastric cancer management with Dr Choo and Prof Kei Muro from Japan. During her session, Dr. Choo shared her clinical experiences and offered practical insights from multinational treatment settings and demonstrating how precision medicine can improve patient outcomes.

Her presentation contributed to rich discussions with fellow experts, highlighting innovative strategies in targeted therapy, and multidisciplinary care. The event attracted strong engagement from the medical community, reaching a total viewership of 12,000 across two major Chinese platforms, underscoring the global interest in advanced gastric cancer treatment and the value of international academic collaboration.

30/12/2025

Day 3 of ESMO Asia featured the Progress and Potential in Targeting RAS in Cancer session, where Dr. Choo presented on RAS Targeting Strategies in GI Cancer, sharing updates on emerging therapies and precision approaches. She was joined by Dr. Shubham Pant, Dr. Daniel Tan, and Dr. Stephen Chan, who offered complementary perspectives on advances in RAS-driven cancers. Definitely a ln unmet need in oncology🔬✨

The session underscored how fast the field is evolving—and the exciting potential these breakthroughs hold for improving patient outcomes.

27/12/2025

Day 2 of ESMO Asia featured a session chaired by Dr. Choo, with Florian Lordick (Leipzig, DE) sharing the latest insights from the ESMO Gastrointestinal Oncology Journal. The discussion focused on CLDN18.2 as a new biomarker in the treatment of gastric cancers. The setting allowed for an interactive session with many questions from the audience. 🌟🔬

25/12/2025

Wishing you a Merry Christmas and a Happy New Year 🎄✨
May the season bring you health, happiness, and warmth.

24/12/2025

On ESMO Asia Day 1, Dr Joline had the privilege of chairing the ESMO satellite symposium on navigating treatment for HR+ HER2- metastatic breast cancer🎗️. The rapid expansion of biomarker-driven therapeutic options in recent years has been remarkable, and learning from our APAC colleagues in Australia and Taiwan about best practices for testing and treatment sequencing was truly inspiring🌏💡.

Dr Choo also had the honor of chairing and moderating this year’s ESMO Women for Oncology (W4O) Forum alongside Dr Janice Tsang from Hong Kong👩‍⚕️👩‍⚕️. They were joined by inspiring colleagues from Spain, New Zealand, Bangladesh, and Singapore for a meaningful discussion on supporting women in oncology to build equitable, fulfilling, and successful careers💪✨. The panel’s personal anecdotes—honest, vulnerable, and powerful—resonated deeply with the room❤️. Their voices reminded us why this work matters and why the mission of W4O continues to be so important. It was truly heartening to see young female oncologists step forward, speak up, and ask thoughtful questions👏. More information on the ESMO W4O committee’s mission can be found here: https://www.esmo.org/career-development/women-for-oncology

Curie also had the honor of being involved in two studies selected for poster presentations📄🔬: one led by Dr Choo on functional drug sensitivity testing in refractory GI cancers, and another on the real-world use of zolbetuximab in gastric cancers in collaboration with NCCS.

21/12/2025

ESMO Asia Symposium – Insight to Impact in Advanced Breast Cancer. Biomarkers driven therapeutic strategy has become the standard of care for hormone receptor positive metastatic breast cancer. In this symposium, Dr. Joline shared insights on therapeutic strategies for metastatic breast cancer post CDK4/6 inhibitor therapy, and discussed how genomic profiling is guiding treatment choices today, helping clinicians provide more personalized and effective care for patients. 🔬💡

18/12/2025

At the Firebird Biologics launch event, Transforming Oncology Care: From Molecular Insights to Patient Wellbeing, Dr. John Chia and Prof. Ho Gwo Fuang shared how Caris molecular profiling is transforming care in endometrial cancer 🔬✨. Dr. Joline Lim highlighted the importance of supportive cancer care, including the benefits of scalp cooling therapy to help combat chemotherapy induced hair loss ❄️💇‍♀️. Patient Sandy’s heartfelt story of her cancer journey reminded us that patients are always at the heart of everything we do ❤️.

The event united leading oncologists and specialists to explore the latest in precision medicine and patient-centered care, sparking meaningful discussions on how molecular insights can enhance outcomes and overall wellbeing.

02/12/2025

On 15 November in Surabaya, Dr. Choo shared the latest updates on Advanced HCC and Advanced Colon Cancer treatments, providing valuable insights into current treatment strategies and developments.

Oncology colleagues from Greater Surabaya presented real-life cases, sparking rich multidisciplinary discussions and collaboration among both onsite and online participants.

It was a meaningful session that strengthened our shared commitment to advancing cancer care. 💡🤝

28/11/2025

Dr. Yvonne had a fruitful time at the 3rd Asia Pacific Leukemia Consortium in Penang, an excellent opportunity for mutual learning and interaction with leukemia experts from the region and around the world. 🌏💉

She was invited to join the AML expert panel and speak at the special AML MRD forum. The event was also attended virtually by participants from China, Taiwan, Vietnam, Malaysia, Singapore, Russia, and the Middle East, making it truly multinational 🤝✨

25/11/2025

On 7 November, Dr. Choo was a speaker at HPB 360: The Multidisciplinary Edge, organised by the Philippine Hepatobiliary and Pancreatic Tumor Foundation in collaboration with hospitals including Cardinal Santos Medical Center and the Medical City, where she shared insights on “A New Era for HCC: Systemic Treatment Breakthroughs.” 💡and joined a multidisciplinary panel of surgeon, hepatologist, oncologist and interventional radiologist to discuss real world cases.

Excited to explore the latest advancements in systemic therapies for hepatocellular carcinoma (HCC) and the multidisciplinary approaches that are shaping the future of patient care. 🤝🌏 She also lectured on advanced pancreatic cancer and shared how molecular testing and targeted therapies are changing the clinical outcomes in this difficult to treat cancer, together with other PH colleagues.

Big thanks to Dr Marie Luisa Tiambeng for the invitation and for organising such a successful event.🎉🌟

21/11/2025

Dr. Joline was invited as a speaker at the Taichung Veterans General Hospital Breast Oncology Summit, where she engaged in a meaningful exchange on the latest updates in ADC use for hormone receptor–positive, HER2-negative breast cancer. 🎤💡

While ADCs were initially developed for HER2-positive breast cancers, their applications have now expanded to triple-negative and hormone receptor–positive disease, with excellent outcomes revolutionizing breast cancer treatment for our patients with advanced disease. 🔬💊

We are grateful for the warm hospitality of our colleagues in Taiwan, as always, and look forward to continued collaboration to improve care for patients across Asia. 🤝🌏

18/11/2025

Dr. Choo presented online at the Bach Mai Hospital Conference, delivering a talk on “Prolonging Survival in Unresectable HCC with Duo Immunotherapy: From Trial to Clinical Practice.”

She shared the latest evidence and practical insights on using combination immunotherapy to improve outcomes for patients with unresectable hepatocellular carcinoma (HCC), bridging clinical trial data with real-world practice, while colleagues in the meeting room engaged in discussion.

Address

Singapore

Opening Hours

Monday	08:30 - 17:30
Tuesday	08:30 - 17:30
Wednesday	08:30 - 17:30
Thursday	08:30 - 17:30
Friday	08:30 - 17:30
Saturday	08:30 - 12:30

Telephone

+6562595538

Website

https://curieoncology.com.sg/

Alerts

Be the first to know and let us send you an email when Curie Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Curie Oncology:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Featured

The Prenatal Consultants
101 Irrawaddy Road, #15-05/06 Royal Square Medical Centre

Want your practice to be the top-listed Clinic in Singapore?